Key points from article :
Gate Bioscience is a biotech company developing a new class of medicines called Molecular Gates.
Molecular Gates are small molecules that eliminate disease-causing extracellular proteins.
These proteins are implicated in a wide range of diseases, including inflammatory conditions, neurodegenerative diseases, and cancers.
Gate's approach targets a ubiquitous mechanism in human biology: the way in which these proteins are secreted and emerge from cells.
Molecular Gates bind to the secretory translocon, a channel in the endoplasmic reticulum, and block disease-causing proteins from exiting the cell.
This prevents these proteins from causing disease and has the potential to treat a wide range of diseases.
The company has recently received $60 Million investment.
